Affram K et al (2020) Comparative study on contrast enhancement of magnevist and magnevist-loaded nanoparticles in pancreatic cancer PDX model monitored by MRI. Cancer Nanotechnol 11:5

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wen X et al (2020) Immuno-SPECT/PET imaging with radioiodinated anti-PD-L1 antibody to evaluate PD-L1 expression in immune-competent murine models and PDX model of lung adenocarcinoma. Nucl Med Biol 86-87:44–51

Article  CAS  PubMed  Google Scholar 

Hidalgo M et al (2014) Patient-derived xenograft models: an emerging platform for translational cancer research. Cancer Discov 4:998–1013

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gao H et al (2015) High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response. Nat Med 21:1318–1325

Article  CAS  PubMed  Google Scholar 

Zhou H et al (2015) IGF1 receptor targeted theranostic nanoparticles for targeted and image-guided therapy of pancreatic Cancer. ACS Nano 9:7976–7991

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhang Y et al (2023) Development and characterization of nanobody-derived CD47 theranostic pairs in solid tumors. Research 6:0077

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pereira PMR et al (2022) Caveolin-1 temporal modulation enhances antibody drug efficacy in heterogeneous gastric cancer. Nat Commun 13:2526

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tully KM et al (2022) Radioimmunotherapy targeting delta-like ligand 3 in small cell lung cancer exhibits antitumor efficacy with low toxicity. Clin Cancer Res 28:1391–1401

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rao Y et al (2023) Statins enhance the efficacy of HER2-targeting radioligand therapy in drug-resistant gastric cancers. Proc Natl Acad Sci USA 120:e2220413120

Article  CAS  PubMed  PubMed Central  Google Scholar 

Abdolahi S et al (2022) Patient-derived xenograft (PDX) models, applications and challenges in cancer research. J Transl Med 20:206

Article  PubMed  PubMed Central  Google Scholar 

Okano M et al (2020) Orthotopic implantation achieves better engraftment and faster growth than subcutaneous implantation in breast cancer patient-derived xenografts. J Mammary Gland Biol Neoplasia 25:27–36

Article  PubMed  PubMed Central  Google Scholar 

Wetterauer C et al (2015) Early development of human lymphomas in a prostate cancer xenograft program using triple knock-out immunocompromised mice. Prostate 75:585–592

Article  PubMed  Google Scholar 

Dieter SM et al (2017) Patient-derived xenografts of gastrointestinal cancers are susceptible to rapid and delayed B-lymphoproliferation. Int J Cancer 140:1356–1363

Article  CAS  PubMed  Google Scholar 

Butler KA et al (2017) Prevention of human lymphoproliferative tumor formation in ovarian cancer patient-derived xenografts. Neoplasia 19:628–636

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bondarenko G et al (2015) Patient-derived tumor xenografts are susceptible to formation of human lymphocytic tumors. Neoplasia 17:735–741

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lin W et al (2018) Establishment and characterization of new tumor xenografts and cancer cell lines from EBV-positive nasopharyngeal carcinoma. Nat Commun 9:4663

Article  PubMed  PubMed Central  Google Scholar 

Mukohyama J et al (2016) Evaluation of the risk of lymphomagenesis in xenografts by the PCR-based detection of EBV BamHI W region in patient cancer specimens. Oncotarget 7:50150–50160

Article  PubMed  PubMed Central  Google Scholar 

Jung J, Seol HS, Chang S (2018) The generation and application of patient-derived xenograft model for cancer research. Cancer Res Treat 50:1–10

Article  PubMed  Google Scholar 

Moy RH et al (2022) Defining and targeting esophagogastric cancer genomic subsets with patient-derived xenografts. JCO Precis Oncol 6:e2100242

Article  PubMed  PubMed Central  Google Scholar 

Liu Y et al (2023) Patient-derived xenograft models in cancer therapy: technologies and applications. Signal Transduct Target Ther 8:160

Article  PubMed  PubMed Central  Google Scholar 

Fujii E et al (2014) Characterization of EBV-related lymphoproliferative lesions arising in donor lymphocytes of transplanted human tumor tissues in the NOG mouse. Exp Anim 63:289–296

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cybula M et al (2021) Patient-derived xenografts of high-grade serous ovarian cancer subtype as a powerful tool in pre-clinical research. Cancers 13:6288

Woo XY et al (2019) Genomic data analysis workflows for tumors from patient-derived xenografts (PDXs): challenges and guidelines. BMC Med Genet 12:92

Google Scholar 

Radaelli E et al (2015) Spontaneous post-transplant disorders in NOD.Cg- Prkdcscid Il2rgtm1Sug/JicTac (NOG) mice engrafted with patient-derived metastatic melanomas. PLoS One 10:e0124974

Article  PubMed  PubMed Central  Google Scholar 

Tillman H, Vogel P, Rogers T, Akers W, Rehg JE (2020) Spectrum of posttransplant lymphoproliferations in NSG mice and their association with EBV infection after engraftment of pediatric solid tumors. Vet Pathol 57:445–456

Article  CAS  PubMed  PubMed Central  Google Scholar 

Santagostino SF, Arbona RJR, Nashat MA, White JR, Monette S (2017) Pathology of aging in NOD scid gamma female mice. Vet Pathol 54:855–869

Article  PubMed  PubMed Central  Google Scholar 

Yang P, Freeman ZT, Dysko RC, Hoenerhoff MJ (2022) Degenerative myelopathy and neuropathy in NOD.Cg-Prkdc(scid) Il2rg(tm1Wjl)/SzJ (NSG) mice caused by lactate dehydrogenase-elevating virus (LDV). Toxicol Pathol 50:390–396

Article  CAS  PubMed  Google Scholar 

Edmondson EF et al (2020) Naturally acquired mouse kidney parvovirus infection produces a persistent interstitial nephritis in immunocompetent laboratory mice. Vet Pathol 57:915–925

Article  CAS  PubMed  Google Scholar 

Mangosing S, Ricart Arbona R, Monette S, Lipman N (2019) Iatrogenic reovirus infection in highly immunocompromised mice. J Am Assoc Lab Anim Sci 58:607–726

Google Scholar